Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Micro Imaging Technology, Inc. (OTC: MMTC).

Full DD Report for MMTC

You must become a subscriber to view this report.

Recent News from (OTC: MMTC)

Micro Imaging Technology and Northern Michigan University Publish a Paper in the Journal of AOAC International
SAN CLEMENTE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Micro Imaging Technology, Inc. (“MIT”) (OTC PINK:MMTC) -- MIT and their collaborators in the lab of Dr. Josh Sharp of Northern Michigan University have jointly published a paper in the peer reviewed Journal of AOAC Intern...
Source: GlobeNewswire
Date: August, 03 2017 08:30
Northern Michigan University Research With MIT 1000 Garners Award
SAN CLEMENTE, CA --(Marketwired - April 29, 2016) - Micro Imaging Technology, Inc. ("MIT") (OTCQB: MMTC)  -- The 2016 Celebration of Student Research competition at Northern Michigan University ("NMU") resulted in a first place Group Poster Award for research consequential to the c...
Source: Marketwired
Date: April, 29 2016 10:44
Micro Imaging Technology Adds STAPH AUREUS to Its Catalog of Identifiers
SAN CLEMENTE, CA --(Marketwired - January 14, 2016) - Micro Imaging Technology, Inc. ("MIT") (OTCQB: MMTC) announced that its MIT 1000 System can now identify Staphylococcus aureus (" S. aureus") , a bacterial pathogen which can cause skin infections and commonly leads to abscess form...
Source: Marketwired
Date: January, 14 2016 08:00
Top 3 Trade Alert Ideas September 25: Exelixis's Cobimetinib, Merck For Dividends, Progenics Catalysts
Exelixis (NASDAQ: EXEL ) Exelixis announced on Friday that the European CHMP has adopted a positive opinion for cobimetinib in combination with vemurafenib for the treatment of advanced melanoma. Cobi is a selective MEK inhibitor and received its first regulatory approval recently. Cobi in...
Source: SeekingAlpha
Date: September, 29 2015 09:29
Micro Imaging Technology Adds Enterococcus Faecalis to Its Catalog of Identifiers
SAN CLEMENTE, CA--(Marketwired - Sep 9, 2015) - Micro Imaging Technology, Inc. ( OTCQB : MMTC ) announced that its MIT 1000 System can now identify Enterococcus faecalis, a bacterial species found in human feces and in the intestines of many warm-blooded animals; occasionally found in uri...
Source: Marketwired
Date: September, 09 2015 07:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MMTC.

About Micro Imaging Technology, Inc. (OTC: MMTC)

Logo for Micro Imaging Technology, Inc. (OTC: MMTC)

A Development stage company, objectives are global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms such as E. coli, Listeria and Salmonella.




Current Management

  • Jeffrey Nunez / CEO
  • Victor A. Hollander / CFO
  • Cathy Patterson / Corporate Secretary
  • Victor A. Hollander /
  • Gregg Newhuis /
  • Jeffrey Nunez /

Current Share Structure

  • Market Cap: $540,870 - 03/09/2018
  • Issue and Outstanding: 9,014,498 - 09/10/2014


Daily Technical Chart for (OTC: MMTC)

Daily Technical Chart for (OTC: MMTC)

Stay tuned for daily updates and more on (OTC: MMTC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MMTC)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MMTC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MMTC and does not buy, sell, or trade any shares of MMTC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: